John T Henderson insider trades

Open-market stock purchases and sales by John T Henderson, Director at Cytokinetics Inc, from SEC Form 4 filings since Jan 4, 2010.

Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -80%.

Recent trades

DateStockTradeValue
Jul 15, 2026CYTK Cytokinetics IncBought (not open market)$22.5K
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
May 5, 2026CYTK Cytokinetics IncSold$1.5M
May 5, 2026CYTK Cytokinetics IncBought (not open market)—
Apr 15, 2026CYTK Cytokinetics IncBought (not open market)$21.2K
Jan 15, 2026CYTK Cytokinetics IncBought (not open market)$21.2K
Dec 2, 2025CYTK Cytokinetics IncSold$559K
Dec 2, 2025CYTK Cytokinetics IncBought (not open market)—
Oct 15, 2025CYTK Cytokinetics IncBought (not open market)$21.2K

Companies traded

  • CYTK Cytokinetics Inc: 1 buy, 16 sales, last Jul 15, 2026
  • MYGN Myriad Genetics Inc: 5 buys, 10 sales, last Dec 5, 2019
  • MYRX Myrexis, Inc: other filings, last Jan 18, 2013

Get free alerts when John T Henderson files a new trade →